Evolution in the real-world therapeutic strategies in more than 20,000 women with breast cancer having received human epidermal growth factor receptor 2–targeted treatments: Results from the french personalized reimbursement model database (2011–2018)

Autor: Xavier Pivot, Anne Doly, Julien Manson, L. Samelson, Paul Cottu, Olivier Aujoulat, Hugues Barletta, Nassera Chalabi, Bruno Coudert, David Pérol

Publikováno v: European Journal of Cancer
European Journal of Cancer, 2020, 141, pp.209-217. ⟨10.1016/j.ejca.2020.10.012⟩
European Journal of Cancer, Elsevier, 2020, 141, pp.209-217. ⟨10.1016/j.ejca.2020.10.012⟩

International audience; Background: There is a growing need for real-world data on cancer treatments usage, especially to assess compliance with recommendations. We developed a French project using hospital data to analyse evolution in the therapeuti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce1dd8c8aad413817f10cd639114d74c
https://hal.science/hal-03493774

Operating room scheduling including medical devices sterilization: towards a transverse logistic

Autor: Benoit Beroule, Olivier Aujoulat, Helene Lustig, Oussama Barakat, Olivier Grunder

Publikováno v: IFAC-PapersOnLine. 49:1146-1151

There is a large number of papers which studies the hospital operating theater management and more precisely the operating room planning and scheduling. The purpose of these researches is to find methods to organize the prescribe surgical procedures

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1764abe3f2244758d05fc64c8e71a036
https://doi.org/10.1016/j.ifacol.2016.07.657

Results of a Prospective Non-Randomized Trial Comparing the Efficacy of Voriconazole (Vor) and Posaconazole (Pos) As Primary Prophylactic Agents of Invasive Fungal Infections (IFI) in Acute Leukemic Patients

Autor: Benoît Lesquerbault, Olivier Aujoulat, Celine Haby, Alain Gravet, Eric Jeandidier, Caroline Lohmann, Catherine Berg, Bernard Drenou, Mario Ojeda-Uribe

Publikováno v: Blood. 118:1120-1120

Abstract 1120 Between 2007–2010 we performed a monocentric non-randomized prospective study to compare Vor (orally or IV 200 mg b.i.d.) to Pos (orally 200 mg t.i.d.) as primary prophylactic antifungals in either de novo or relapsed leukemic patient

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d55af19e1dd1780a117b2b4c9602bb50
https://doi.org/10.1182/blood.v118.21.1120.1120

FrontMatter.

Publikováno v: Swarm Intelligence Based Optimization: Second International Conference, ICSIBO 2016, Mulhouse, France, June 13-14, 2016, Revised Selected Papers; 2016, pI-IX, 9p

Successful rapid desensitization to the antibody–drug conjugate brentuximab vedotin in a patient with refractory Hodgkin lymphoma.

Autor: Fizesan, Marie, Boin, Christopher, Aujoulat, Olivier, Newinger, Georges, Ghergus, Dana, Watier, Hervé, Lustig, Hélène, Ojeda-Uribe, Mario

Publikováno v: Journal of Oncology Pharmacy Practice; Feb2016, Vol. 22 Issue 1, p188-192, 5p, 2 Charts, 1 Graph